Toft Group Completes Executive Search for Mesa Biotech, Inc., in San Diego, CA
Executive search firm Toft Group has placed Mr. Steven Sepulveda as the Vice President, Global Business Development & Channel Management for Mesa Biotech, Inc., in San Diego, CA. He brings 15+ years in sales and corporate development, most recently serving in leadership roles for Sekisui Diagnostics and Horiba Medical.
About Mesa Biotech
Mesa Biotech is an emerging molecular diagnostic company, bringing the superior diagnostic performance of nucleic acid amplification to the point-of-care (POC). Mesa Biotech's diagnostic system consists of a portable, palm-sized dock and a disposable, assay-specific test cassette. This patented system will allow healthcare professionals to obtain actionable, laboratory-quality results at the POC in 30 minutes or less with greater sensitivity and specificity than many current infectious disease rapid immunodiagnostic tests. Mesa's technology development has been funded to date by a series of grants and private equity investments totaling approximately $30 million. The company is preparing for Series A funding in 2016 and expects to obtain FDA approval for its first product, an influenza assay and dock, in 2017.